Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY:CC)

13.87 +0.43 (+3.20%)
Streaming Delayed Price Updated: 9:58 AM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Chemours Company (The) Common Stock

Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2023
 
Via Benzinga
Finding 20 Dividend Growth Stocks In A Bad Market
Starting in 2012, it became more and more difficult for prudent dividend growth stock investors looking for income. The stock market was trading at excessive valuations, and interest rates were at... 
Via Talk Markets
Overview Of Value Stocks In The Basic Materials Sector
 
Via Benzinga
Where Chemours Stands With Analysts
Within the last quarter, Chemours (NYSE:CC) has observed the following analyst ratings: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
 
Via Benzinga
Analyst Ratings for Chemours
 
Via Benzinga
Chemours (CC) Q3 2022 Earnings Call Transcript
CC earnings call for the period ending September 30, 2022. 
Via The Motley Fool
Chemours Unveils Ti-Pure™ Sustainability (TS) Product Series, Designed to Advance Company & Customers’ Sustainability Goals Through TiO2 Innovation
From The Chemours Company
Via Business Wire
This Industrial Stock Looks Dirt Cheap. Is It a Buy?
There is a lot to like about The Chemours Company, but there is one issue that should give investors pause. 
Via The Motley Fool
Chemours and Honeywell Announce Program to Enable Reclamation and Recycling of Refrigerants in Support of Circular Economy
From The Chemours Company
Via Business Wire
Earnings Scheduled For October 25, 2022
Companies Reporting Before The Bell • UBS Gr (NYSE:UBS) is expected to report earnings for its third quarter. • SAP (NYSE:SAP) is expected to report earnings for its third quarter. 
Via Benzinga
Analyst Ratings for Chemours
Chemours (NYSE:CC) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Chemours and BOHN Collaborate to Innovate the Cold Food Chain, Launching the First Low GWP Solution in the Americas Based on A2L Technology
From The Chemours Company
Via Business Wire
10 Spin-Off Stocks That Pay Dividends
10 spin-offs from recent years that now pay dividends after being separated from their parent companies. 
Via Talk Markets
The Chemours Company Reports Third Quarter 2022 Results
From The Chemours Company
Via Business Wire
Expert Ratings for Chemours
Analysts have provided the following ratings for Chemours (NYSE:CC) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
Upgrades 
Via Benzinga
Chemours Announces Fourth Quarter Dividend
From The Chemours Company
Via Business Wire
Chemours and the University of Delaware Unveil the Center for Clean Hydrogen
From The Chemours Company
Via Business Wire
Chemours Begins Operation of Trail Ridge South Mineral Sand Mine in Florida
From The Chemours Company
Via Business Wire
Chemours Announces Joint Venture Agreement with BWT to Enable the Capacity and Innovation Required by the Transportation Fuel Cell Market
From The Chemours Company
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Upgrades 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022
Upgrades 
Via Benzinga
Chemours Announces Dates for Third Quarter 2022 Earnings Release and Webcast Conference Call
From The Chemours Company
Via Business Wire
Chemours Announces $200 Million Investment to Expand Capacity and Technology in Response to Growing Global Demand for Hydrogen Solutions
From The Chemours Company
Via Business Wire
McDonald's Price Target Cut By This Analyst, Plus Cowen Predicts $362 For Domino's Pizza
Citigroup cut McDonald's Corporation (NYSE: MCD) price target from $275 to $246. McDonald's shares rose 0.5% to $245.00 in pre-market trading. 
Via Benzinga
Spero Therapeutics To Rally Around 240%? Plus This Analyst Slashes PT On Salesforce
Evercore ISI Group raised the price target on Spero Therapeutics, Inc. (NASDAQ: SPRO) from $2 to $8. Evercore ISI Group analyst Josh Schimmer also upgraded the stock from In-Line to Outperform. Spero... 
Via Benzinga
UnitedHealth To Rally 24%? Here Are 5 Other Price Target Changes For Thursday
Raymond James raised the price target on UnitedHealth Group Incorporated (NYSE: UNH) from $620 to $635. Raymond James analyst John Ransom maintained the stock with a Strong Buy rating. UnitedHealth... 
Via Benzinga
Chemours Commends the U.S. Senate for Ratification of the Kigali Amendment
From The Chemours Company
Via Business Wire
Chemours, Alcoa And Other Big Losers From Wednesday
U.S. stocks closed lower with the Dow Jones dropping more than 500 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.